Showing results (441-450 of 770) with videos related to

Sort By:
Pageof 77
Neurology|November 7, 2008
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapyO Stüve, P D Cravens, E M Frohman, et al.
Neurology|September 1, 2007
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINELP A Calabresi, G Giovannoni, C Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2013
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease durationH Kearney, M A Rocca, P Valsasina, et al.
Neurology|April 18, 2007
Natalizumab reduces visual loss in patients with relapsing multiple sclerosisL J Balcer, S L Galetta, P A Calabresi, et al.
European Journal of Neurology|January 26, 2008
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI studyC Wegner, M Filippi, T Korteweg, et al.
European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.
Neuroimage|June 27, 2008
Reproducibility of fMRI in the clinical setting: implications for trial designsR Bosnell, C Wegner, Z T Kincses, et al.
Experimental Brain Research|February 1, 2008
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibitionS C Manson, C Wegner, M Filippi, et al.
Physical Review Letters|September 16, 2000
Two-body B meson decays to eta and eta('): observation of B --> eta K*S J Richichi, H Severini, P Skubic, et al.
Physical Review Letters|September 16, 2000
Measurement of charge asymmetries in charmless hadronic B meson decaysS Chen, J Fast, J W Hinson, et al.
Pageof 77